Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

EBR:KIN - Euronext Brussels - BE0974274061 - Common Stock - Currency: EUR

34.45  -0.25 (-0.72%)

Fundamental Rating

4

Taking everything into account, KIN scores 4 out of 10 in our fundamental rating. KIN was compared to 47 industry peers in the Entertainment industry. There are concerns on the financial health of KIN while its profitability can be described as average. KIN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year KIN was profitable.
In the past year KIN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KIN reported negative net income in multiple years.
Of the past 5 years KIN 4 years had a positive operating cash flow.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 3.54%, KIN is doing good in the industry, outperforming 65.96% of the companies in the same industry.
The Return On Equity of KIN (17.91%) is better than 74.47% of its industry peers.
The Return On Invested Capital of KIN (7.04%) is better than 72.34% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KIN is below the industry average of 9.18%.
The 3 year average ROIC (6.76%) for KIN is below the current ROIC(7.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.54%
ROE 17.91%
ROIC 7.04%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

KIN has a better Profit Margin (7.00%) than 65.96% of its industry peers.
In the last couple of years the Profit Margin of KIN has declined.
KIN has a better Operating Margin (14.20%) than 80.85% of its industry peers.
KIN's Operating Margin has declined in the last couple of years.
The Gross Margin of KIN (24.01%) is worse than 91.49% of its industry peers.
KIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.2%
PM (TTM) 7%
GM 24.01%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KIN is creating some value.
KIN has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for KIN has been increased compared to 5 years ago.
The debt/assets ratio for KIN has been reduced compared to a year ago.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

KIN has an Altman-Z score of 1.49. This is a bad value and indicates that KIN is not financially healthy and even has some risk of bankruptcy.
KIN's Altman-Z score of 1.49 is fine compared to the rest of the industry. KIN outperforms 63.83% of its industry peers.
The Debt to FCF ratio of KIN is 6.27, which is on the high side as it means it would take KIN, 6.27 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.27, KIN is in line with its industry, outperforming 55.32% of the companies in the same industry.
KIN has a Debt/Equity ratio of 2.70. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.70, KIN is not doing good in the industry: 72.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.7
Debt/FCF 6.27
Altman-Z 1.49
ROIC/WACC1.31
WACC5.39%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

KIN has a Current Ratio of 0.52. This is a bad value and indicates that KIN is not financially healthy enough and could expect problems in meeting its short term obligations.
KIN's Current ratio of 0.52 is on the low side compared to the rest of the industry. KIN is outperformed by 80.85% of its industry peers.
A Quick Ratio of 0.49 indicates that KIN may have some problems paying its short term obligations.
KIN's Quick ratio of 0.49 is on the low side compared to the rest of the industry. KIN is outperformed by 80.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.49
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

KIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.79%.
The Earnings Per Share has been decreasing by -5.80% on average over the past years.
The Revenue has decreased by -4.51% in the past year.
Measured over the past years, KIN shows a small growth in Revenue. The Revenue has been growing by 0.95% on average per year.
EPS 1Y (TTM)-27.79%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%15.09%
Revenue 1Y (TTM)-4.51%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%4.74%

3.2 Future

Based on estimates for the next years, KIN will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.82% on average per year.
Based on estimates for the next years, KIN will show a small growth in Revenue. The Revenue will grow by 4.98% on average per year.
EPS Next Y48.8%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
EPS Next 5Y15.82%
Revenue Next Year6.99%
Revenue Next 2Y6.63%
Revenue Next 3Y5.68%
Revenue Next 5Y4.98%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2 3

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.44 indicates a rather expensive valuation of KIN.
Compared to the rest of the industry, the Price/Earnings ratio of KIN indicates a somewhat cheap valuation: KIN is cheaper than 76.60% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of KIN to the average of the S&P500 Index (26.31), we can say KIN is valued inline with the index average.
The Price/Forward Earnings ratio is 13.81, which indicates a correct valuation of KIN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN indicates a somewhat cheap valuation: KIN is cheaper than 76.60% of the companies listed in the same industry.
KIN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.44
Fwd PE 13.81
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KIN is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, KIN is valued cheaper than 80.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.79
EV/EBITDA 9.86
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

KIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN's earnings are expected to grow with 24.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y31.49%
EPS Next 3Y24.23%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.11%, KIN has a reasonable but not impressive dividend return.
KIN's Dividend Yield is a higher than the industry average which is at 1.82.
With a Dividend Yield of 1.11, KIN pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

36.36% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP36.36%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (6/13/2025, 7:00:00 PM)

34.45

-0.25 (-0.72%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)08-21 2025-08-21
Inst Owners15.64%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap942.90M
Analysts86
Price Target50.49 (46.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP36.36%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.3%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.37%
Valuation
Industry RankSector Rank
PE 23.44
Fwd PE 13.81
P/S 1.63
P/FCF 7.79
P/OCF 5.76
P/B 4.17
P/tB 24.2
EV/EBITDA 9.86
EPS(TTM)1.47
EY4.27%
EPS(NY)2.49
Fwd EY7.24%
FCF(TTM)4.42
FCFY12.84%
OCF(TTM)5.98
OCFY17.36%
SpS21.12
BVpS8.25
TBVpS1.42
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 17.91%
ROCE 9.58%
ROIC 7.04%
ROICexc 7.81%
ROICexgc 10.3%
OM 14.2%
PM (TTM) 7%
GM 24.01%
FCFM 20.93%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.7
Debt/FCF 6.27
Debt/EBITDA 3.71
Cap/Depr 52.05%
Cap/Sales 7.37%
Interest Coverage 3.53
Cash Conversion 99.8%
Profit Quality 299.1%
Current Ratio 0.52
Quick Ratio 0.49
Altman-Z 1.49
F-Score5
WACC5.39%
ROIC/WACC1.31
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.79%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%15.09%
EPS Next Y48.8%
EPS Next 2Y31.49%
EPS Next 3Y24.23%
EPS Next 5Y15.82%
Revenue 1Y (TTM)-4.51%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%4.74%
Revenue Next Year6.99%
Revenue Next 2Y6.63%
Revenue Next 3Y5.68%
Revenue Next 5Y4.98%
EBIT growth 1Y-22.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year112.63%
EBIT Next 3Y32.23%
EBIT Next 5Y22.36%
FCF growth 1Y2.2%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y5.96%
OCF growth 3Y22.57%
OCF growth 5Y1.63%